Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Janux Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Janux Therapeutics Inc
Rating: 1.12116675
Author: Trendlyne DVM scores

about

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

23.91 -0.32 (-1.32%)

66.66% Fall from 52W High

732.8K

XNAS Volume

XNAS 31 Jul, 2025 3:51 PM (EDT)

Board Meeting

The next board meeting for Janux Therapeutics Inc is on 07 Aug 2025 for the purpose of Janux Therapeutics Inc Second Quarter Earnings Results for 2025 See details